Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Cardiovascular implantable electronic device (CIED) consists of pacemakers for bradyarrhythmia treatment, implantable cardioverter defibrillators (ICDs) for tachyarrhythmia management, and cardiac resynchronization therapy (CRT) devices for systolic dysfunction with conduction delays. Cardiac implant devices include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy, implantable hemodynamic monitoring, and implanted heart rhythm monitors that are also known as loop recorders. These implants are used for treating myocardial ischemia, arrhythmias, and acute myocardial infraction.

Aging population and demographic changes across the world are expected to increase prevalence of heart disease, which in turn, is expected to increase demand for cardiac implantable electronic devices over the forecast period. According to the American College of Cardiology, as of 2017, cardiovascular diseases accounted for around 800,000 deaths in the U.S and it remains the leading cause of death in the country.

Cardiac Implantable Electronic Device Market - Impact of Coronavirus (Covid-19) Pandemic

During this COVID-19 pandemic situation, the global cardiac implantable electronic device market has caused an influx of patients in hospitals and acute care facilities. As a result, any procedure or service is being shut down immediately. Many hospitals have already categorized cardiac implantable device as ‘non-essential’. Patients with cardiovascular disease are at high risk of being affected by COVID-19 infection, which can lead to death.  

The global cardiac implantable electronic device market is estimated to be valued at US$ 22,576.22 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027).

Figure 1: Global Cardiac Implantable Electronic Device Market Share (%) Analysis, By Type, 2020

Cardiac Implantable Electronic Device  | Coherent Market Insights

Increasing launches of cardiac implantable electronic devices are expected to drive growth of the global cardiac implantable electronic device market

New product launches by market players, owing to technological advancements in implantable cardiac pacemakers is expected to drive growth of the market. For instance, in 2017, Boston Scientific Corporation launched the Resonate family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems featuring the Heart Logic Heart Failure Diagnostic to help physicians improve heart failure (HF) management and also, the device was approved in 2017 by the U.S. FDA for conditional use in a magnetic resonance imaging (MRI) environment.

Global Cardiac Implantable Electronic Device Market - Restraints

However, implantable pacemaker associated infections in cardiac patients can deter patients from using this product, which is expected to negatively impact growth of the market.

request-sample

Cardiac Implantable Electronic Device Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 22,576.22 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.7% 2027 Value Projection: US$ 38,027.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Implantable Pacemakers, External Pacemakers.
  • By End User: Hospitals, Specialty Clinics, Ambulatory Care Settings.
Companies covered:

Medtronic plc., Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Braile Biomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc.

Growth Drivers:
  • Increasing incidence of cardiac arrhythmias
  • Increasing launches of cardiac implantable electronic device
Restraints & Challenges:
  • Infections associated with installation of pacemakers

Global Cardiac Implantable Electronic Device Market – Regional Analysis

North America accounted for the largest share in the global cardiac implantable electronic device market in 2019, owing to increasing prevalence of cardiovascular diseases in the region. According to the American Heart Association (AHA), 2017, around 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke.

Furthermore, Asia Pacific is also expected to witness significant growth in the global cardiac implantable electronic device market, owing to high demand for technologically advanced products for cardiac rhythm management and rising healthcare concern for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of which 2.9 million may suffer from AF-associated strokes.

Figure 2: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Cardiac Implantable Electronic Device  | Coherent Market Insights

Global Cardiac Implantable Electronic Device Market - Competitive Landscape

Key players operating in the global cardiac implantable electronic device market include Medtronic plc., Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Braile Biomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc..

Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias, and other heart related disorders. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in the recent years, which has improved quality of life in patients with heart failure.

Market Dynamics

The increasing incidence of cardiac arrhythmia is expected to drive growth of the cardiac implantable electronic device market. For instance, according to the Anesthesia Patient Safety Foundation 2013, around 14.4 million patients in the U.S. suffer from cardiac arrhythmia and it accounts for around 40,700 deaths, annually.

However, factors such as chances of infections associated with the installation of pacemakers in cardiac patients can hamper the cardiac implantable electronic device market growth. Pacemaker surgery can also lead to various complications such as bleeding, bruising or swelling at the of area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can reduce the adoption of cardiac implants by patients.

Key features of the study:

  • This report provides in-depth analysis of the global cardiac implantable electronic device market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global cardiac implantable electronic device market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies
  • Key players covered as a part of this study include Medtronic plc., Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Braile Biomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global cardiac implantable electronic device market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cardiac implantable electronic device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Cardiac Implantable Electronic Device Market, By Type:
    • Implantable Pacemakers
    • External Pacemakers
  • Global Cardiac Implantable Electronic Device Market, By Application:
    • Arrhythmia
    • Heart Block
    • Others
  • Global Cardiac Implantable Electronic Device Market, By End User:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Care Settings
  • Global Cardiac Implantable Electronic Device Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Type:
        • Implantable Pacemakers
        • External Pacemakers
      • By Application
        • Arrhythmia
        • Heart Block
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Care Settings
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Type:
        • Implantable Pacemakers
        • External Pacemakers
      • By Application
        • Arrhythmia
        • Heart Block
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Care Settings
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Type:
        • Implantable Pacemakers
        • External Pacemakers
      • By Application
        • Arrhythmia
        • Heart Block
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Care Settings
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Type:
        • Implantable Pacemakers
        • External Pacemakers
      • By Application
        • Arrhythmia
        • Heart Block
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Care Settings
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Type:
        • Implantable Pacemakers
        • External Pacemakers
      • By Application
        • Arrhythmia
        • Heart Block
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Care Settings
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Type:
        • Implantable Pacemakers
        • External Pacemakers
      • By Application
        • Arrhythmia
        • Heart Block
        • Others
      • By End User:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Care Settings
  • Company Profiles
    • Medtronic plc
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Biotronik
    • Boston Scientific Corporation
    • Shree Pacetronix Ltd.
    • CCC Medical Devices
    • Cook Group Incorporated
    • Braile Biomédica
    • Abbott Laboratories
    • Sorin Group
    • Osypka Medical GmbH
    • Galix Biomedical Instrumentation Inc.
    • Oscor Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Technological Advancements
    • Key Developments
    • Acquisition, Collaborations & Partnerships
    • Epidemiology
    • PEST Analysis
    • Porter’s Analysis
  4. Impact Analysis of Covid-19
    • Supply side Analysis
    • Demand Side Analysis
    • Impact on Healthcare Industry
  5. Global Cardiac Implantable Electronic Device Market, By Type, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Implantable Pacemakers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • External Pacemakers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Cardiac Implantable Electronic Device Market, By End User, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Specialty Clinics
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Care Settings
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Cardiac Implantable Electronic Device Market, By Region, 2016 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • Medtronic plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Biotronik
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Shree Pacetronix Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • CCC Medical Devices
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Cook Group Incorporated
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Braile Biomédica
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sorin Group
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Osypka Medical GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Galix Biomedical Instrumentation Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Oscor Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 26 market data tables and 25 figures on "Global Cardiac Implantable Electronic Device Market” - Forecast to 2027”

Frequently Asked Questions

The CAGR of the global cardiac implantable electronic device market is expected to be 7.7% during the forecast period (2020-2027).
The value of the global cardiac implantable electronic device market is estimated to be US$ 22,576.22 million in 2020.
The prominent players in the global cardiac implantable electronic device market include Medtronic plc. Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, Braile Biomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc.
The global cardiac implantable electronic device market is expected to be valued at US$ 38,027.8 Mn in 2027.
North America is the major region in the global cardiac implantable electronic device market.
Increasing incidence of cardiac arrhythmias and increasing launches of cardiac implantable electronic devices are key factors driving growth of this market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner